Page 6 - Best Colonoscopy doctors: TOP 149 doctors

Dr. José Miguel Esteban López-Jamar is a gastroenterologist. He has led the Digestive Endoscopy and Digestive Diseases Units at Hospital Ruber Internacional since 2007. He has more than 20 years of experience. He is a Spanish pioneer in endoscopic ultrasound (EUS). His work covers diagnostic and interventional endoscopy. He uses innovative, minimally invasive techniques for complex gastrointestinal disease.

He was Head of Endoscopy (2008–2012) and Head of Endoscopic Innovation (2012–2014) at Hospital Clínico San Carlos. He completed international training at AMC Amsterdam, Institut Paoli-Calmettes in Marseille, and Zhongshan Hospital in Shanghai. He holds an MD and a PhD from the Complutense University of Madrid. He is a specialist in gastroenterology. He takes part in multicenter European studies and clinical trials. He is a member of SEPD, SEED, and ESGE.

Gastroenterology

Pendik Medipol University Hospital

Education

1999 Karadeniz Technical University, Gastroenterology

1997 Atatürk University, Internal Diseases Professorship

1992 Atatürk University, Internal Diseases Associated Professorship

1985 Atatürk University, Internal Diseases Specialist

1981 Atatürk University Faculty of Medicine

Publications

1- Nihat Okçu Gülçin Polat, Arif Yılmaz, Mehmet Koruk, The demographic features of gastric cancers in Erzurum(Eurasian J Med 2000; 32: 63-65)

2- An Evaluation of Upper Gastrointestinal Bleeding Cases. Clinical Sciences-Doctor.2000, - E.akarsu,N.Okçu,et Ark.Northeast Anatolia 6:4:435-438

3-N.Okçu, A.yılmaz. İ.kiki,MDonuk, C.gündoğdu, H.uzunismail. Our Diagnostic Upper Gastrointestinal Endoscopy Results. Atatürk University Medical Journal 1997,29 (2):486

4-N. Okçu, M.gündoğdu, MD onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, I. çapoğlu. The Role of Misoprostol in Preventing Gastroduodenal Lesions in Patients Using Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Atatürk University Medical Journal 1997,29 (2):453-455.

5-N.Okçu, A. Öz, MD Onuk, E.Akarsu, B. Tekin, Hz Tonbul, H.Kaya. Plasma Fibronectin Levels in Chronic Active Hepatitis and Decoction of Liver Parenchymal Insufficiency and Their Relationship with Liver Functional Status. Turkish J. Gastroenterol 1995;27(4): 422-426.

6-N.Okçu, Tahir Buran, MD Onuk, A. Yılmaz, E.Akarsu, G. Akçay. Prevalence of Helicobacter Pylori in Patients with Duodenal Ulcer in Erzurum and Surrounding Area. Turkish J. Gastroenterol 1995;27(4): 447-450.

7-N.Okçu, bs awake, e. akarsu, e. bakan, z. tonbul. Importance of Carbohydrate Antigens (CA-19-9, CA-125), Carcinoembryonic Antigen (CEA) and Alkaline Phosphatase in Gastric and Colorectal Cancers. Turkish J. Gastroenterol 1995;6:467-471.

8-N. Okçu, MD Onuk, E. Akarsu, H. Doğan, C. Gündoğdu. Major Risk Factors in Patients with Hepatocellular Carcinoma in Our Region. Gastroenterology 1994;5(2):154-157

9-N.Okçu, md. Onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Frequency of gastric carcinoma in Erzurum region, endoscopic and histological features. Gastroenterology 1994;5(2):263-267.

10-N. Okçu, MD Onuk, Tahir Buran, E. Akarsu, MA Çiftçioğlu. Frequency of Helicobacter Pylori in Nonspecific Gastritis Cases in Erzurum Province. Gastroenterology 1994;5(2):211-213.

11-N.Okçu, MD Onuk, Ö. Ünal, E. Akarsu, L. İncesu, K. Akgöz. Diagnostic Value of Ultrasound-Guided Fine Needle Aspiration Biopsy in Intra-Abdominal Mass Lesions. Gastroenterology 1993;4(1):166-68.

12-NOkçu, md. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Syndrome (2 Cases). Turkish J Gastroenterhepatol 1993; 4(1):77-80.

13-N.Okçu, H. Koçak, MD Onuk, M. Gündoğdu, E. Bakan, A. Yılmaz, A. Başoğlu, A. Ateş, F.A. Paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriuretic Peptide (ANP) Levels. Vascular Surgery 1993; 27(2): 128-132

15-N.Okçu, MD Onuk, A.Yılmaz, M. Gündoğdu, T. Buran. Effects of Omeprozole and Ranitidine on Peptic Ulcer Healing. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.

16-N. Okçu, Mr. Yiğitoğlu, B. Adam, E. Bakan. The Effect of Digixin on Plasma Atrial Natriuretic Peptic Level in Patients with Congestive Heart Failure. S.Ü. Medical Faculty Journal 1991;7(2):243-247..

17-N.Okçu, A. Yılmaz. The Effect of Histamine H2 -Receptor Antagonists in Upper Gastrointestinal System Bleeding. Endoscopy Journal 1991;2(4):17-23.

18-N.Okçu, E. Bakan, B. Adam, A. Yılmaz, Mr. Yiğitoğlu. Sex Hormones and Sex Hormone Binding Globulin Levels in Patients with Chronic Hepatitis and Liver Cirrhosis (Letter to the Editor). Nature-Tr. J. Of Medical Sciences 1991;15:1-2.

19-N.Okcu Ömer Yılmaz.Helıcobacter pylori and related gastrointestinal system diseases. Turkish Clinics JMed Sci. 2013;33(3):806-13

20-Nihat Okçu, Ömer Yılmaz, Hakan Dursun, Gülçin Polat. The relationship between dyspeptic symptoms, nutritional habits, endoscopic and histological findings (Eurasian J Med 2006; 38: 13-17)

21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayir,1Ibrahim Pirim,2Salim B. Tekin,1andCemal Gundogdu3 - Distribution of HLA Tissue Groups in Patients with Gastric Cancer Eurasian J Med. 2010 Apr; 42(1): 9.11.

22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu:The fibroblast proliferation, relationship of hepatocyte growth factor (HGF) and interferon-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404

23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sari,Nihat Okcu,Abdulhalim Baki. The effect of fish oil on stress ulcer prophylaxis GastroenterologyVolume 118, Issue 4, Part 2, PageA1255

Position:

Associate Professor ,

General Surgery Department

ISTANBUL MEDIPOL UNIVERSITY PENDIK HOSPITAL General Surgery Department

PERSONAL INFORMATION

Birth Date: 14.05.1982 

Place of Birth      : Şanlıurfa, Türkiye

Married, father of one.

CITIZENSHIP:

Republic of Turkey

EDUCATION:

Specialization:

General Surgery Department

Istanbul Kartal Dr. Lütfü Kırdar Training and Research Hospital (2009- 2014)

University

Istanbul University Istanbul Faculty of Medicine (20022008)

Anadolu University Faculty of Business Administration - Administration of Health Institutions (2013-2015)

Anadolu University Faculty of Open Education Department of Law (2016-)

High school

Erzincan Science High School (1998-2002)

Working Experience:

ERZINCAN NEVZAT AYAZ SCIENCE HIGH SCHOOL 1998-2002

ISTANBUL UNIVERSITY ISTANBUL FACULTY 2002-2009

GENERAL SURGERY ASSISTANT ISTANBUL KARTAL DR. LUTFI KIRDAR TRAINING AND RESEARCH HOSPITAL 2009-2014

SPECIALIST PHYSICIAN MEDENIYET UNIVERSITY GOZTEPE TRAINING AND RESEARCH HOSPITAL 2014-2015

CHIEF PHYSICIAN T.R.  MINISTRY OF HEALTH SILOPI STATE HOSPITAL 2015-2016

SPECIALIST PHYSICIAN T.R. MINISTRY OF HEALTH DERINCE TRAINING AND RESEARCH HOSPITAL, 2018-2020

SPECIALIST PHYSICIAN SANLIURFA MEHMET AKIF INAN TRAINING AND RESEARCH HOSPITAL 2016-2018

ASSOCIATE PROFESSOR ISTANBUL KARTAL DR. LUTFI KIRDAR CITY HOSPITAL 2020-2023

İSTANBUL MEDIPOL UNIVERSITY PENDIK HOSPITAL 2023-

PUBLICATIONS

National and International Articles

1 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2021). Inguinal hernia repair via laparoscopic transabdominal preperitoneal (TAPP) method: Our 2 years clinical results. Annals of Medical Research, 28(4), 812-815., Doi: 10.5455/annalsmedres.2020.05.443

2 SAĞIROĞLU ŞÜKRİYE JÜLİDE, ÖZDEMİR TUĞRUL, ATAK TUBA, GÖK MEHMET ALİ, ORHUN ERDOĞAN KIVILCIM, EREN TURGUT TUNÇ, ALİMOĞLU ORHAN (2016). Laparoscopic Total Extraperitoneal Inguinal Hernia Repair Without Mesh Fixation: Report of Early Outcomes. SouthernPrint Date :22/10/2022 17:41:41 Clinics of Istanbul Eurasia, 27(3), 215-219., Doi: 10.14744/scie.2017.64872 

3 ÇİFTÇİ ALİ, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2022). Management of Acute Biliary Pancreatitis in Cholecystectomized Patients. Bezmiâlem Science, 10(4), 507-511. Doi: 10.14235/ bas galenos. 2021.6708

4 GÖK MEHMET ALİ, YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, KOCAOĞLU AYTAÇ EMRE (2022). Gastrointestinal Stromal Tümörlerde İmmünohistokimyasal Markırların ve Tümör Boyutunun Prognoz Üzerindeki Rolü. Kocaeli Tıp Dergisi, 10(2), 101-104. M-784-1650 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). Laparoscopic transabdominal preperitoneal repair of strangulated femoral hernia: Superiority of an unusual emergency surgical approach due to a case. Annals of Medicine and Surgery, 36(1), 110-112.

5 GÖK MEHMET ALİ, KARADAYI BÜYÜKÖZSOY AYŞEGÜL, KAFADAR MEHMET TOLGA (2022). The sensitivity of ultrasound in the clinical diagnosis of inguinal hernias in adults: a comparative study. Journal of Ultrasound, 1-4., Doi: 10.1007/s40477-021-00641-4

6 KARADAYI BÜYÜKÖZSOY AYŞEGÜL, KARATAY EMRAH, GÖK MEHMET ALİ (2022). Comparison of the Effectiveness of Ultrasound Imaging and Perioperative Measurement in the Diagnosis and Characterization of Incisional Hernia. Journal of Medical Ultrasound, 1-5.

7 GÖK MEHMET ALİ, DEMİR MUSTAFA, YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, ŞENOL METİN, KOCAOĞLU AYTAÇ EMRE, AKIN EMRAH (2022). Endoscopic Intra-gastric Botulinum Toxin A for Obesity Treatment: IsIt Effective?. Kocaeli Tıp Dergisi, 11(2), 149-152.

8 GÖK MEHMET ALİ, KARATAY EMRAH, ÇİFTÇİ ALİ (2022). İnguinal Hernilerde Balonsuz ve Mesh Sabitleyicisiz Laparoskopik Total Ekstraperitoneal Onarımın Cerrahi Deneyim ile Korelasyonu. Dicle Medical Journal, 49(3), 498-503., Doi: 10.5798/dicletip.1170263

9 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). Effects of Carvedilol on Liver İschemiaReperfusion İnjury in Rats. Ulusal Travma ve Acil Cerrahi Dergisi-Turkish Journal of Trauma & Emergency Surgery, 28(7), 885-893.

10 ŞENOL METİN, GÖK MEHMET ALİ (2022). Small Bowel Obstruction due to Phytobezoar. Kocaeli Tıp Dergisi, 11(2), 1-6.

11 KARATAY EMRAH, GÖK MEHMET ALİ, JAVADOV MIRKHALIG (2021). Measurement of hiatal surface area and other hiatus oesophageal diameters at computed tomography imaging in patients with gastroesophageal reflux disease and its relationship with hiatal hernia. Journal of Minimal Access Surgery, 17(4), 537-541., Doi: 10.4103/jmas.JMAS_175_20

12 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2021). Perforated colorectal cancers; clinical outcomes \nof 18 patients who underwent emergency surgery. Gastroenterology Review, 16(2), 161-165., Doi: 10.5114/pg.2021.106667

13 YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2020). Comparison of Perioperative Standard and Immunomodulating Enteral Nutrition in Patients Received Major Abdominal Cancer Surgery: a Prospective, Randomized, Controlled Clinical Trial. Indian Journal of Surgery, 82, 828-834., Doi: 10.1007/s12262-020-02114-0 

14 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2020). Effects of Preoperative Oral Carbohydrate Loading on Preoperative and Postoperative Comfort in Patients Planned to Undergo Elective Cholecystectomy: A Prospective Randomized Controlled Clinical Trial. Iranian Red Crescent Medical Journal, 22(11), 1-6., Doi: 10.32592/ircmj.2020.22.11.107

15 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2019). Comparison of negative-pressure incision management system in wound dehiscence: A prospective, randomized, observational study. Journal of Medicine and Life, 12(3), 276-283., Doi: 10.25122/jml-2019-0033

16 KAFADAR MEHMET TOLGA, YALÇIN METİN, DADÜK YILDIRAY, SOYALP MURAT, GÖK MEHMET ALİ (2018). Laparoscopic Cholecystectomy for Acute Cholecystitis in Situs Inversus Totalis: An Extraordinary Approach. Eurasian Journal of Emergency Medicine, 17(2), 82-84.

17 KAFADAR MEHMET TOLGA, TEKER İBRAHİM, GÖK MEHMET ALİ, UĞURLU ESAT TAYLAN, ÇETİNKAYA ISMAİL (2018). Atraumatic splenic rupture secondary to abscess in a hemodialysis patient: a rare and fatal cause of acute abdomen diagnosed late. Journal of Surgical Case Reports,5, 1-3., Doi: 10.1093/jscr/rjy103

18 KAYA FERUDUN, KAFADAR MEHMET TOLGA, KISMET KEMAL, GÖK MEHMET ALİ, ERTAŞ ERTUĞRUL (2018). Congenital Transmesenteric Hernia Without Bowel Strangulation in a Young Adult. The Medical Bulletin Of Haseki, 56(4), 337-340., Doi: 10.4274/haseki.galenos.2022.8361

19 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, GÜNEŞ ABDULLAH (2018). Laparoscopic treatment of hepatic hydatid disease: Şanlıurfa-Turkey experience and early clinical outcomes. Laparoscopic Endoscopic Surgical Science, 25(3), 98-102., Doi:14744/less.2018.4353171203046744-1078.03 Basım Tarihi 22/10/2022 17:41:41 Sayfa: 2

20 KAFADAR MEHMET TOLGA, YALÇIN METİN, GÖK MEHMET ALİ, AKTAŞ AYŞEGÜL, YÜREKLİ TACİTTİN SEMİH, ARSLAN AYŞEGÜL İSAL (2017). intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor. intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor, 13(3), 156-168., Doi: 10.5152/ejbh.2017.3472

 21 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, ÖTER VOLKAN (2017). Early-term elective laparoscopic resection after endoscopic detorsion in cases with sigmoid colonic volvulus. Annals of Clinical and Analytical Medicine, 8(6), 492-495., Doi: 10.4328/JCAM.5231

22 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ, ÖTER VOLKAN (2017). Late-diagnosed penetrating stab Wounds in diaphragm and herniation. Annals of Clinical and Analytical Medicine, 8(4), 367-369., Doi: 10.4328/JCAM.5103

23 ANADOLULU ALİ İHSAN, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ, ANADOLULU ZEYNEP (2017). Laparoscopic spleen-preserving distal pancreatectomy with splenic vessel preservation for pancreatic pseudocyst in a 10-year-old boy. Journal of Pediatric Surgery Case Reports, 34(1), 10-12.

Proceedings

National and International Proceedings

İnguinal Hernilerde Total Ekstraperitoneal Onarımda Balon Disseksiyonu ile Teleskopik Disseksyonun   Kıyaslanması, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). 22.. Ulusal Cerrahi Kongresi, 

İNSİZYONEL HERNİLERDE LAPAROSKOPİK VE KONVANSİYONEL ONARIM YÖNTEMLERİ ARASINDAPOSTOPERATİF AĞRI, GÖK MEHMET ALİ, JAVADOV MIRKHALIG (2021). 8.. Ulusal Fıtık Kongresi

Laparaskopık total ekstraperıitoneal (TEP) onarımında redükte edilemeyen keseler enerji

cıihazıyla lıigate edılebırlıir mı , KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2019). 7..

Ulusal Fıtık Kongresi

TEK İNSİZYON LAPARASKOPİK TOTAL EKSTRAPERİTONEAL İNGUİNAL HERNİ ONARIMI DENEYİMİMİZ, GÖK MEHMET ALİ, DEMİR MUSTAFA (2019). 14.. Endoskopik Laparoskopik Cerrahi Kongresi

Laparaskopik Sleeve Gastrektomide 3D Görüntüleme Sisteminin Etkiniliği , GÖK MEHMET ALİ, KAYA FERUDUN, KAFADAR MEHMET TOLGA, AKSOY BAŞAR (2017). 2.. Bariatrik ve Metabolik Cerrahi Kongresi

İnsizyonel hernide laparaskopik preperitoneal onarım, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2017).. 9.. Cerrahi Araştırma Kongresi

ERCP Yapılan Kist Hidatikli Hastalarda Kist Küçülür mü, YALÇIN METİN, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2017).. 13.. Türk Hepatopankreatobilier Cerrahi Kongresi

İnsizyonel Hernilerde TAPP Onarım Mümkün mü, GÖK MEHMET ALİ, AKSOY BAŞAR, KAFADAR MEHMET TOLGA, YALÇIN METİN (2017).. 6.. Ulusal Fıtık Kongresi, (Özet bildiri)

HİATAL HERNİLERDE LAPAROSKOPİK YAKLAŞIM, GÖK MEHMET ALİ, YALÇIN METİN, KAFADAR MEHMET TOLGA, YILMAZ TACETTİN SEMİH, AKTAŞ AYŞEGÜL (2017).. 13.. Endoskopik Laparoskopik Cerrahi Kongresi

KLİNİĞİMİZDE İNGUİNAL HERNİDE 3 TEKNİĞİN KARŞILAŞTIRLMASI, YALÇIN METİN, GÖK MEHMET ALİ, ÇEKİÇ TOLGA FARUK, KABALAK BİLAL, ÖTER VOLKAN, AKTAŞ AYŞEGÜL (2017). Ulusal Endoskopik Laparoskopik Cerrahi Kongresi

Kolon Divertikül  Perforasyonlarında Hartmann Prosedürü veya Primer Anastomoz? , GÖK MEHMET ALİ, KEŞKÜŞ BRAHIM H. HÜDAVERDI, BÖZKURT AHMET ÇAĞLAR, YALÇIN METİN, YILMAZ TACETTİN SEMİH (2017).. 11.. Ulusal Travma ve Acil Cerrahi Kongresi, (Özet bildiri)

GASTROİNTESTİNAL PREKANSEROZ LEZYONLARDA ENDOSKOPİK MUKOZAL REZEKSİYONUN ROLÜ, ORMAN SÜLEYMAN, GÖK MEHMET ALİ, EREN TURGUT TUNÇ, LEBLEBİCİ METİN, ALİMOĞLU ORHAN (2015). 12.. Ulusal Endoskopik Laparoskopik Cerrahi Kongresi

PİYES MAMAOGRAFİSİNDE KİTLE YOK! NE YAPILMALIM, ESER MEHMET, HATİPOĞLU HAYAT, GÜNDOĞAN ERSİN, GÖK MEHMET ALİ, ÇETİN KENAN, ACAR AYLİN, TAN SEDAT, BİLDİK NECDET (2014).. 19.. Ulusal Cerrahi Kongresi

LAPAROSKOPİK KOLESİSTEKTOMİ YAPILAN HASTALARDA TROKAR YERİ FITIĞI GELİŞİMİNDE ETKİLİ OLABİLECEK FAKTÖRLERİN ARAŞTIRILMASI, GÖK MEHMET ALİ, KÜNDEŞ MUHAMMED FİKRİ, KEMENT METİN, ATICI ALİ EMRE, KAPTANOĞLU LEVENT, İLHAN NOYAN, CAN UĞUR, BİLDİK NEJDET, VURAL SELAHATTİN (2014).. 19.. ULUSAL CERRAHİ KONGRESİ 

Books

Written sections in international books

1)Genel Cerrahide Nadir Görülen Acil ve Elektif Vakalar, Bölüm adı:(Akciğere Fistülize Karaciğer Kist Hidatik Vakasına Acil Laparoskopik Yaklaşım) (2020)., COŞKUN MURAT, GÖK MEHMET ALİ,

Akademisyen Yayınevi, Editör: Ender ANILIR Mehmet BAYRAK Mehmet Tolga KAFADAR Mert TANAL Ali Emre NAYCI Hüseyin KILAVUZ Özlem Öndeş BAYAR, Basım sayısı:1, Sayfa Sayısı 655, ISBN:978- 625-7275-23-1, Türkçe(Bilimsel Kitap)

2)Gastrointestinal Sistem Kanserlerinin Cerrahisi, Bölüm adı:(Karaciğerin Primer Solid MalignNeoplazileri) (2020)., GÖK MEHMET ALİ, Akademisyen Yayınevi, Editör: Hüseyin Özgür AYTAÇ, Basım sayısı:1, Sayfa Sayısı 404, ISBN:978-605-258-949-6, Türkçe (Bilimsel Kitap)

3)Gastrointestinal Sistem Tümörleri-1, Bölüm adı:(ERKEN EVRE HASTALIKTA CERRAHİ TEDAVİ) (2019)., GÖK MEHMET ALİ, Akademisyen Yayınevi, Basım sayısı:1, Sayfa Sayısı 493, ISBN:978-605-258-551-1, Türkçe (Bilimsel Kitap)

Editorship

1) Minimal İnvaziv Cerrahi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 22.10.2020-15.07.2021

2. YENİ NESİLCERRAHİ, Kitap, Editör, Akademisyen Kitapevi A.Ş., 15.06.2021-15.08.2022

3. Onkolojik Cerrahi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 05.04.2021-05.12.2021

4.. Fıtık Cerrahisi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 07.04.2020-07.11.2020

Certificates

Hernia A to Z Fundemantals Hands on Workshop, Laparoscopic Hernia Surgery Experience Certificate in Cadaver was awarded by the European Hernia Society.

. DUBAİ/ U.A.E, 28.11.2018 

CADAVER TRAINING EVENT IN COLON AND RECTAL SURGERY, Robotic Colorectal Surgery in Cadaver training certificate was given.  STONY BROOK UNİVERSİTY / NEWYORK/ USA,.04.2016

Memberships in Scientific Organizations:

1.. Turkish Society of Colon and Rectum Surgery, Member, 2020

2.. Turkish Surgical Association, Member, 2014

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

The doctor completed medical studies at the University of Vienna in 1998, with training at UCLA and the University of Pennsylvania. From 2000 to 2006, the doctor trained as a specialist in internal medicine at Vienna General Hospital, followed by additional specialization in gastroenterology and hepatology from 2006 to 2008, and internal intensive care medicine from 2008 to 2010.

The doctor established and managed the hepatic hemodynamics laboratory and the outpatient clinic for cirrhosis at the Medical University of Vienna in 2003. Since 2018, the doctor has been head of the Department for Internal Medicine I at the Hospital of the Barmherzigen Brüder Vienna.

The doctor is a specialist in general and visceral surgery, serving as a surgeon at the Department of General Surgery at the Medical University of Vienna. Leading the gastric and esophageal surgery team, the doctor is also the Head of the Gastroesophageal Tumor Unit at the Comprehensive Cancer Center in Vienna.

With over 240 specialized articles published, the doctor has held significant roles such as General Secretary of the Austrian Society of Surgical Oncology since 2014 and Head of Upper-GI-Service since 2012. The doctor is an Associate Professor for Surgery and has been a specialist in upper-GI-surgery since 2007.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

The doctor graduated from Istanbul University Cerrahpasa Faculty of Medicine and has extensive experience in internal medicine and gastroenterology. Specialized training was completed at Haydarpaşa Numune Training and Research Hospital, focusing on gastroenterology. The doctor has held positions at various hospitals, including Haydarpasha Nummune Hospital and Shishli Etfal Training and Research Hospital, and has worked at Unimed Private Polyclinic and Hospitallium Camlica.

Expertise includes procedures such as esophagogastroduodenoscopy, colonoscopy, chromoendoscopy, and various treatments for gastrointestinal bleeding and strictures. The doctor is proficient in advanced techniques like esophageal varicose band ligation and percutaneous endoscopic gastrostomy.

Dr. Osman Aktas has been serving as a general surgeon at Ataşehir Avicenna Hospital since 2005. Born in Kayseri in 1960, he graduated with his medical degree from Ankara University in 1983. Following his graduation, he fulfilled his military service in medical units for two years. He completed his general surgery residency at GATA from 1986 to 1990. After specializing in general surgery, He held key positions as head of general surgery departments and chief physician in several prominent military hospitals, including Tatvan, Diyarbakır, Ankara, and Manisa.

Dr. Osman has had a special focus on endoscopic surgery since 1995. He received advanced training in laparoscopic surgery techniques in Germany and has successfully performed a wide range of laparoscopic procedures. His expertise extends to gallbladder surgery, abdominal wall and inguinal hernia repairs, appendicitis, reflux and stomach surgeries, as well as complex cases such as gastrointestinal tumors, intestinal obstructions, and various other intestinal diseases, all managed through minimally invasive methods.

In 2002, Dr. Osman transitioned to the private sector, where he broadened his practice to include modern treatments for anal diseases like hemorrhoids, fistulas, and fissures, utilizing advanced techniques such as laser therapy.

Dr. Osman is also recognized for his significant contributions to oncological surgery. He has a wealth of experience in the surgical treatment of various cancers, including breast and thyroid cancer, where he has implemented new treatment methods that reduce the risk of complications. His surgical expertise spans critical cancer surgeries, such as the Whipple procedure for pancreatic cancer, colorectal cancer resections, gastric cancer, and other complex malignancies. Additionally, his skills in metabolic surgery have led to lasting outcomes for patients suffering from obesity and diabetes, ensuring a better quality of life through sustained weight loss and reduced risk of diabetes.

With his vast experience and advanced skills in both laparoscopic and cancer surgeries, Dr. Osman remains at the forefront of surgical excellence, offering innovative and comprehensive care to all his patients.

Dr. Abu Shamsiya Rami Nuamanovych is a specialist in general and laparoscopic surgery, oncology, and ultrasound diagnostics. He is a Candidate of Medical Sciences, an associate professor, and a doctor of the highest category. Dr. Nuamanovych is a member of the Ukrainian Association of Bariatric Surgeons and the World Organization of Bariatric Surgeons (IFSO).

He works as a WHO consultant on laparoscopic surgery. He is also President of the Association of Arab Doctors of Ukraine. Dr. Nuamanovych has performed thousands of surgeries, including hernia repairs, bariatric procedures, and cancer operations. His skills are recognized internationally. He speaks English and Arabic fluently.

The doctor has 17 years of experience in Upper GI and Weight Loss Surgeries, being among the first in India trained in Banded Bypass, Banded Sleeve Gastrectomy, and Mini Gastric Bypass in Los Angeles, USA. He performs the innovative Sleeve Gastrectomy with Duodeno-jejunal bypass, known for its effectiveness in weight loss and Type II Diabetes Mellitus resolution, especially for vegetarian patients. Trained in Italy for Robotic GI Surgery, he utilizes advanced techniques for precision and recovery.

Practicing Weight Loss and Metabolic Surgery with Minimally Invasive Techniques since 2009, only 1% of his patients experience significant morbidity, aligning with global standards. Over 90% of diabetic patients maintain a healthy lifestyle without insulin or oral medications.

The doctor handles complex bariatric cases, including Sleeve Gastrectomy, Gastric Bypass, and Revision Bariatric Surgery. He is skilled in advanced minimally invasive and robotic upper GI and Biliopancreatic surgeries, with multiple publications and international speaking engagements.

The department of bariatric surgery is certified as a center of excellence by the International Excellence Foundation.

Education

Doctor: Kilis Merkez No. 1 Health Center, 2006-2008
Assistant Doctor: Mersin University Faculty of Medicine, 2009-2013
Specialist Doctor: Bingöl Genç State Hospital, 2013-2014
Minor Assistant: Akdeniz University Faculty of Medicine, 2014-2017
Minor Specialist: Erzurum Regional Training and Research Hospital, 2017-2018
Subspecialist: Gaziosmanpaşa Training and Research Hospital, 2018-2020
Attending Specialist: Başakşehir Çam and Sakura City Hospital, 2020-2022
Associate Professor: Başakşehir Çam and Sakura City Hospital, 2023
Associate Professor: Istinye University Medicalpark Gaziosmanpaşa Hospital, 2023-2024

Scientific Memberships

Turkish Pediatric Society
Turkish Society for Pediatric Gastroenterology Hepatology and Nutrition
ESPGHAN - European Society for Pediatric Gastroenterology Hepatology and Nutrition.

Medical Intrests

• 
  -Irritable (Restless) Bowel Syndrome
• -Food allergies associated with the digestive system
• -Constipation, faecal incontinence
• -Acute and chronic diarrhoea, malabsorption
• -Chronic abdominal pain
• -Gastroesophageal reflux disease
• -Celiac disease
• -Ulcerative colitis, Crohn's disease
• -Treatment before and after liver transplantation
• -Acute and chronic pancreatitis

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

Medical Intrests

• Breast Cancer
• Lung Cancer
• Colon Cancer
• Stomach Cancer
• Rectal Cancer
• Ovarian Cancer
• Liver Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Kidney Cancer
• Larynx Cancer - Cancer of the Larynx
• Thyroid Cancer
• Head and Neck Cancers
• Gynaecological Cancers
• Pancreatic Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Uterine Cancer
• Brain Cancers - Brain Tumours
• Soft Tissue Cancer - Sarcomas
• Prostate Cancer
• Bladder Cancer
• Bile Tract Cancer
• Testicular Cancer
• Cervical Cancer
• Mouth, Tongue, Lip Cancers
• Gastrointestinal System Cancers
• Bone Tumours
• Trachea and Bronchial Cancers
• Skin Cancers - Skin Cancers
• Skeletal System Tumours
• Gallbladder Cancer
• Mesothelioma

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Dr. Holovyna Svitlana is a gastroenterologist and nutritionist with more than 23 years of experience. She is a member of the Association of Dietitians and Gastroenterologists of Ukraine. She also belongs to the European Association for the Study of the Liver (EASL) and the Association of Preventive and Anti-Age Medicine.

Dr. Holovyna diagnoses and treats gastrointestinal disorders, metabolic diseases, and nutrition-related issues. She uses an integrated and evidence-based approach. Her focus is on restoring digestive health, managing chronic conditions, and improving patient well-being with personalized diet and treatment plans.

Education

İnönü Üniversitesi Tıp Fakültesi (ingilizce) 1995- 2002

Work Experience

Başbakanlık S.H.Ç.E.K. Genel Müdürlüğü Kurum Hekimliği (2003)

Erciyes Üniversitesi Tıp Fakültesi Genel Cerrahi Uzmanlığı 2011

Yüzüncü Yıl Üniversitesi Temel ve İleri Düzey Endoskopik Girişimler Eğitimi 2011

İstanbul Hastanesi /Van 2011

Özel Malatya Hastanesi / Malatya2012

Bilgi Tıp Merkezi Keçiören /Ankara 2013

Özel Koru Sincan Hastanesi Sincan/Ankara 2013

Baş Tibb Mərkəzi /Baku Clinic Azerbaycan/Bakü 2013

Yüksek İhtisas Üniversitesi Özel Koru Ankara Hastanesi 2019

Özel Ankara Koru Hastanesi /Ankara 2019

Medical Interests

laparoscopic obesity
Laparoscopic abdominal and inguinal hernia repairs (with the latest techniques)

Postpartum laparascopic diastasis recti (the formation of a protrusion in the upper middle abdomen due to the separation of the muscles in the abdominal tissue) and abdominal hernias above the navel and and gobekustunde both diastasis recti repair and abdominal hernia repair from the skin with laparascopic scola method for the first time in Turkey laparascopic stomach hernia and antireflu surgery).  

Laparoscopic gallbladder surgeries, including cleaning the bile duct with trans-cystic choledochal irrigation in patients with bile sludge and stones less than 5mm in the bile duct, performed in the same session

Laparoscopic gallbladder surgeries in pregnant women during the 2nd and 3rd trimesters, i.e., after 12 weeks of pregnancy

Laparoscopic Appendectomy in Pregnancy

Anal disorders, anal fissures, all types of internal and external hemorrhoid surgeries, anal fissure, and anal fistula surgeries

Thyroid surgeries and cancers, parathyroid surgeries and cancers

Breast diseases and breast cancer surgery

Oncological surgery; liver and gallbladder and bile duct surgeries, stomach cancer surgery, colon cancer surgery, and liver resections for metastatic liver tumors

The doctor completed specialization training in Radiation Oncology at Marmara University Faculty of Medicine from 2012 to 2016. Prior to this, the doctor completed an undergraduate degree in Medicine, taught in English, at the same institution from 2004 to 2011. The doctor has a strong foundation in medical education, beginning with high school education at Sixteen Numbered Shirvan School in Azerbaijan from 1998 to 2004.